Florida Healthcare Providers · Senate Bill 1768 · For Investigational Use Per FL Statute
RA
REVIVE AESTHETICS
PPX™ Distribution Confidential · 2026
Patient Pure X™ · Autologous EVs

Inject
your EVs.

PPX™ is the patient's own platelet-derived extracellular vesicles — collected chair-side, concentrated in an FDA-registered laboratory, and documented with a per-prep certificate of analysis. The body's own messengers, brought to specification.

400B
Max EV
Concentration
2
1mL Vials
Per Prep
~1wk
Turnaround
Draw to Delivery
COA
Per-Prep Documentation
Sterility · Particle Count
PPX Autologous EVs
Inject Your EVs Patient Pure X™ Autologous · Patient-Derived 100B · 200B · 400B EV FDA-Registered Lab cGMP Processing COA Per Prep FL Senate Bill 1768 Inject Your EVs Patient Pure X™ Autologous · Patient-Derived 100B · 200B · 400B EV FDA-Registered Lab cGMP Processing COA Per Prep FL Senate Bill 1768

Cell-to-cell messengers. Concentrated.

Extracellular vesicles are the body's natural cell-to-cell signaling system, carrying proteins and microRNA between cells. PPX™ isolates these vesicles from the patient's own platelets, then concentrates and documents the recovered fraction.

Nanoparticle Tracking Analysis of PPX
Nanoparticle Tracking Analysis · 200–400 billion EVs/mL · Avg. mode size <100nm
i · The Biology
Cell-to-cell signaling.
Extracellular vesicles act as the body's natural messengers — delivering proteins and microRNA between cells. Roughly 1/1000 the width of a human hair.
ii · The Source
Patient-derived.
PPX™ starts with the patient's own platelets, drawn chair-side. Multi-step centrifugation isolates the platelet-derived EV fraction from the rest of the plasma.
iii · The Output
Lab-defined.
Two 1mL vials per prep. 100B / 200B / 400B EV concentration options. Each prep ships with a certificate of analysis documenting sterility, identity, and nanoparticle count.

Three steps. One product.

PPX™ ships you a complete processing kit — needles, tubes, return packaging. The draw happens in your chair. The concentration happens in an FDA-registered lab. The prep ships back ready to inject.

i
Chair-Side
Draw the
blood.
Use the included PPX™ Processing Kit for a standard chair-side blood draw. Sample is sealed and returned overnight to the FDA-registered lab.
ii
Lab Processing
Isolate
the cargo.
High-speed centrifugation separates the plasma fraction, removes all cell types, and concentrates the platelet-derived EV payload. Each batch is tested for microbial and viral contamination.
iii
Return + Inject
Two vials.
Ready.
In approximately one week, the final preparation ships back to your office in two 1mL vials with a per-prep certificate of analysis confirming sterility and nanoparticle count.

Three concentrations. One molecule of choice.

Each tier delivers documented extracellular vesicle counts — verified by nanoparticle tracking analysis on every prep.

Standard
100B
Extracellular Vesicles
Entry-tier autologous EV concentration for chair-side protocols where lower nanoparticle volume is appropriate.
Maximum
400B
Extracellular Vesicles
Highest available autologous EV concentration. For protocols requiring maximum nanoparticle delivery per dose.

Four standards. Verifiable.

Autologous biologics live or die on documentation. PPX™ standardizes the manufacturing and documents every prep. Every time.

i · Autologous

Patient's own.

PPX™ starts with the patient's own platelets — drawn chair-side. Fully autologous means no donor concerns, no allogenic regulatory questions, no compatibility issues.

ii · Concentrated

Just the EVs.

Multi-step centrifugation removes red cells, leukocytes, and plasma debris. What's left is the concentrated platelet-derived EV fraction — the cargo that carries growth factors and microRNA.

iii · Documented

COA per prep.

Every preparation ships with a certificate of analysis documenting sterility, identity, and nanoparticle count — confirming exactly what's in the vial before it reaches the patient.

iv · Chair-Side

Office-ready.

A standard chair-side blood draw is sealed and shipped overnight to an FDA-registered, cGMP-compliant lab. Multi-step centrifugation isolates the EV fraction. Final product ships back in two 1mL vials, ready to inject.

Three categories. Florida physicians only.

Per Florida Senate Bill 1768 (effective July 1, 2025), stem cell therapies as defined in the statute are available to FL physicians for the following therapeutic indications.

Indication 01
Orthopedics
Joint, tendon, and ligament protocols across the spine and extremities. Two 1mL vials per prep allow staged or single-site delivery.
Indication 02
Pain
Management
Chronic pain protocols including peri-articular and trigger-point applications. Compatible with standard ultrasound-guided injection workflows.
Indication 03
Wound Care
Topical and infiltration applications for chronic wound protocols where autologous EV-rich preparations are clinically indicated.

Documented. Traceable. Defensible.

Autologous biologics live or die on documentation. Here's the paper trail that comes standard with every PPX™ prep.

Built into every prep.
Each PPX™ preparation ships with a per-prep certificate of analysis confirming sterility, identity, and nanoparticle count — alongside chain-of-custody from blood draw to delivery. The infrastructure that protects your license travels with the vial.
FDA
Registered Laboratory
Documented Protocols
cGMP
Compliant Processing
Environmental Controls
COA
Per-Prep Documentation
Sterility · Nanoparticle Count
SB 1768
FL Statute Compliant
Authorized Indications
— Revive Aesthetics · PPX™ Distribution —

Inject your EVs.

Patient's Own · Concentrated · Documented

See it in action.

Drop your details and we'll be in touch within 24 hours to coordinate a demo, kit pricing, or a quick strategy call for your practice.

W revivemymedspa.com
IG @revive.arm
RE PPX Autologous EVs

By submitting you agree to be contacted by Revive Aesthetics about PPX Autologous EVs. We don't share your information.